Rick E. Winningham - Nov 19, 2021 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
Nov 19, 2021
Transactions value $
-$95,337
Form type
4
Date filed
11/23/2021, 07:20 PM
Previous filing
Aug 24, 2021
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability -$95.3K -11.4K -0.87% $8.36 1.3M Nov 19, 2021 Direct F1
holding TBPH Ordinary Shares 92.6K Nov 19, 2021 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.